Key facts
- This page summarizes Scott Hutton's Form 4 filing for BIODESIX INC (BDSX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 May 2024, 19:13.
Scott Hutton - 23 May 2024 Form 4 Insider Report for BIODESIX INC (BDSX)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- BDSX
- Reported as of
- 23 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 May 2024, 19:13:28 UTC
- Prior SEC filing
- 10 May 2024
- Next SEC filing
- 12 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Scott Hutton filed Form 4 for BIODESIX INC (BDSX) on 23 May 2024.
Change
- Previous filing in this sequence was filed on 10 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BDSX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +26,120
- Change %
- +5.4%
- Price
- Shares after
- 509,900
- Date
- 23 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BDSX
transaction
Derivative
Series A Non-Voting Convertible Preferred Stock
Options Exercise
- Transaction value
- $0
- Shares
- -653
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 23 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 26,120
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.